The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global mRNA Raw Enzyme Market Research Report 2025
Synopsis
mRNA raw enzyme is the key raw material in the production of mRNA vaccine and drugs. The research, development and production of mRNA drugs involve restriction endonuclease, RNA polymerase, capping enzyme, Poly (A) polymerase and other enzyme materials.
In this report, mRNA Raw Enzyme includes Restriction Enzyme, RNA Polymerase, Capping Enzyme, Inorganic Pyrophosphatase, RNase Inhibitor, 2'-O-Methyltransferase, Poly(A) Polymerase and DNase I.
The global mRNA Raw Enzyme market was valued at US$ 3654.3 million in 2023 and is anticipated to reach US$ 1233 million by 2030, witnessing a CAGR of -7.7% during the forecast period 2024-2030.
The key global manufacturers of mRNA raw enzymes are Thermo Fisher, NEB, TriLink Bio Technologies, Merck, Aldevron, Qiagen N.V., Promega, Roche CustomBiotech, and others. The top two manufacturers together account for 50% of the market share, with the largest manufacturer being Thermo Fisher, accounting for 27% of the market share. The global origin is mainly distributed in North America, Europe, China, Japan, etc. From the consumer level, North America holds the largest market share, accounting for 40%. In terms of its product category, capping enzymes hold the largest market share with 25%, followed by 2'-O-methyltransferase and inorganic pyrophosphatase with 20% and 13%, respectively. In terms of applications, biopharmaceutical companies are the top application area with 80% of the market share, while the rest of the applications are in academic and research institutions.
This report aims to provide a comprehensive presentation of the global market for mRNA Raw Enzyme, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Raw Enzyme.
Report Scope
The mRNA Raw Enzyme market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global mRNA Raw Enzyme market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Raw Enzyme companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher
NEB
TriLink Bio Technologies
Merck
Aldevron
Qiagen N.V.
Promega
Roche CustomBiotech
Takara Bio Inc.
Novoprotein
Vazyme
Hongene Biotech Corporatio
Segment by Type
Restriction Enzyme
RNA Polymerase
Capping Enzyme
Inorganic Pyrophosphatase
RNase Inhibitor
2'-O-Methyltransferase
Poly(A) Polymerase
DNase I
Others
Segment by Application
Biopharmaceutical Companies
Academic and Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of mRNA Raw Enzyme companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
mRNA raw enzyme is the key raw material in the production of mRNA vaccine and drugs. The research, development and production of mRNA drugs involve restriction endonuclease, RNA polymerase, capping enzyme, Poly (A) polymerase and other enzyme materials.
In this report, mRNA Raw Enzyme includes Restriction Enzyme, RNA Polymerase, Capping Enzyme, Inorganic Pyrophosphatase, RNase Inhibitor, 2'-O-Methyltransferase, Poly(A) Polymerase and DNase I.
The global mRNA Raw Enzyme market was valued at US$ 3654.3 million in 2023 and is anticipated to reach US$ 1233 million by 2030, witnessing a CAGR of -7.7% during the forecast period 2024-2030.
The key global manufacturers of mRNA raw enzymes are Thermo Fisher, NEB, TriLink Bio Technologies, Merck, Aldevron, Qiagen N.V., Promega, Roche CustomBiotech, and others. The top two manufacturers together account for 50% of the market share, with the largest manufacturer being Thermo Fisher, accounting for 27% of the market share. The global origin is mainly distributed in North America, Europe, China, Japan, etc. From the consumer level, North America holds the largest market share, accounting for 40%. In terms of its product category, capping enzymes hold the largest market share with 25%, followed by 2'-O-methyltransferase and inorganic pyrophosphatase with 20% and 13%, respectively. In terms of applications, biopharmaceutical companies are the top application area with 80% of the market share, while the rest of the applications are in academic and research institutions.
This report aims to provide a comprehensive presentation of the global market for mRNA Raw Enzyme, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Raw Enzyme.
Report Scope
The mRNA Raw Enzyme market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global mRNA Raw Enzyme market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Raw Enzyme companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Thermo Fisher
NEB
TriLink Bio Technologies
Merck
Aldevron
Qiagen N.V.
Promega
Roche CustomBiotech
Takara Bio Inc.
Novoprotein
Vazyme
Hongene Biotech Corporatio
Segment by Type
Restriction Enzyme
RNA Polymerase
Capping Enzyme
Inorganic Pyrophosphatase
RNase Inhibitor
2'-O-Methyltransferase
Poly(A) Polymerase
DNase I
Others
Segment by Application
Biopharmaceutical Companies
Academic and Research Institutes
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of mRNA Raw Enzyme companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Raw Enzyme Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Restriction Enzyme
1.2.3 RNA Polymerase
1.2.4 Capping Enzyme
1.2.5 Inorganic Pyrophosphatase
1.2.6 RNase Inhibitor
1.2.7 2'-O-Methyltransferase
1.2.8 Poly(A) Polymerase
1.2.9 DNase I
1.2.10 Others
1.3 Market by Application
1.3.1 Global mRNA Raw Enzyme Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Biopharmaceutical Companies
1.3.3 Academic and Research Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global mRNA Raw Enzyme Market Perspective (2019-2030)
2.2 mRNA Raw Enzyme Growth Trends by Region
2.2.1 Global mRNA Raw Enzyme Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 mRNA Raw Enzyme Historic Market Size by Region (2019-2024)
2.2.3 mRNA Raw Enzyme Forecasted Market Size by Region (2025-2030)
2.3 mRNA Raw Enzyme Market Dynamics
2.3.1 mRNA Raw Enzyme Industry Trends
2.3.2 mRNA Raw Enzyme Market Drivers
2.3.3 mRNA Raw Enzyme Market Challenges
2.3.4 mRNA Raw Enzyme Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top mRNA Raw Enzyme Players by Revenue
3.1.1 Global Top mRNA Raw Enzyme Players by Revenue (2019-2024)
3.1.2 Global mRNA Raw Enzyme Revenue Market Share by Players (2019-2024)
3.2 Global mRNA Raw Enzyme Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by mRNA Raw Enzyme Revenue
3.4 Global mRNA Raw Enzyme Market Concentration Ratio
3.4.1 Global mRNA Raw Enzyme Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Raw Enzyme Revenue in 2023
3.5 mRNA Raw Enzyme Key Players Head office and Area Served
3.6 Key Players mRNA Raw Enzyme Product Solution and Service
3.7 Date of Enter into mRNA Raw Enzyme Market
3.8 Mergers & Acquisitions, Expansion Plans
4 mRNA Raw Enzyme Breakdown Data by Type
4.1 Global mRNA Raw Enzyme Historic Market Size by Type (2019-2024)
4.2 Global mRNA Raw Enzyme Forecasted Market Size by Type (2025-2030)
5 mRNA Raw Enzyme Breakdown Data by Application
5.1 Global mRNA Raw Enzyme Historic Market Size by Application (2019-2024)
5.2 Global mRNA Raw Enzyme Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America mRNA Raw Enzyme Market Size (2019-2030)
6.2 North America mRNA Raw Enzyme Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America mRNA Raw Enzyme Market Size by Country (2019-2024)
6.4 North America mRNA Raw Enzyme Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe mRNA Raw Enzyme Market Size (2019-2030)
7.2 Europe mRNA Raw Enzyme Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe mRNA Raw Enzyme Market Size by Country (2019-2024)
7.4 Europe mRNA Raw Enzyme Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific mRNA Raw Enzyme Market Size (2019-2030)
8.2 Asia-Pacific mRNA Raw Enzyme Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific mRNA Raw Enzyme Market Size by Region (2019-2024)
8.4 Asia-Pacific mRNA Raw Enzyme Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America mRNA Raw Enzyme Market Size (2019-2030)
9.2 Latin America mRNA Raw Enzyme Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America mRNA Raw Enzyme Market Size by Country (2019-2024)
9.4 Latin America mRNA Raw Enzyme Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa mRNA Raw Enzyme Market Size (2019-2030)
10.2 Middle East & Africa mRNA Raw Enzyme Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa mRNA Raw Enzyme Market Size by Country (2019-2024)
10.4 Middle East & Africa mRNA Raw Enzyme Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher
11.1.1 Thermo Fisher Company Detail
11.1.2 Thermo Fisher Business Overview
11.1.3 Thermo Fisher mRNA Raw Enzyme Introduction
11.1.4 Thermo Fisher Revenue in mRNA Raw Enzyme Business (2019-2024)
11.1.5 Thermo Fisher Recent Development
11.2 NEB
11.2.1 NEB Company Detail
11.2.2 NEB Business Overview
11.2.3 NEB mRNA Raw Enzyme Introduction
11.2.4 NEB Revenue in mRNA Raw Enzyme Business (2019-2024)
11.2.5 NEB Recent Development
11.3 TriLink Bio Technologies
11.3.1 TriLink Bio Technologies Company Detail
11.3.2 TriLink Bio Technologies Business Overview
11.3.3 TriLink Bio Technologies mRNA Raw Enzyme Introduction
11.3.4 TriLink Bio Technologies Revenue in mRNA Raw Enzyme Business (2019-2024)
11.3.5 TriLink Bio Technologies Recent Development
11.4 Merck
11.4.1 Merck Company Detail
11.4.2 Merck Business Overview
11.4.3 Merck mRNA Raw Enzyme Introduction
11.4.4 Merck Revenue in mRNA Raw Enzyme Business (2019-2024)
11.4.5 Merck Recent Development
11.5 Aldevron
11.5.1 Aldevron Company Detail
11.5.2 Aldevron Business Overview
11.5.3 Aldevron mRNA Raw Enzyme Introduction
11.5.4 Aldevron Revenue in mRNA Raw Enzyme Business (2019-2024)
11.5.5 Aldevron Recent Development
11.6 Qiagen N.V.
11.6.1 Qiagen N.V. Company Detail
11.6.2 Qiagen N.V. Business Overview
11.6.3 Qiagen N.V. mRNA Raw Enzyme Introduction
11.6.4 Qiagen N.V. Revenue in mRNA Raw Enzyme Business (2019-2024)
11.6.5 Qiagen N.V. Recent Development
11.7 Promega
11.7.1 Promega Company Detail
11.7.2 Promega Business Overview
11.7.3 Promega mRNA Raw Enzyme Introduction
11.7.4 Promega Revenue in mRNA Raw Enzyme Business (2019-2024)
11.7.5 Promega Recent Development
11.8 Roche CustomBiotech
11.8.1 Roche CustomBiotech Company Detail
11.8.2 Roche CustomBiotech Business Overview
11.8.3 Roche CustomBiotech mRNA Raw Enzyme Introduction
11.8.4 Roche CustomBiotech Revenue in mRNA Raw Enzyme Business (2019-2024)
11.8.5 Roche CustomBiotech Recent Development
11.9 Takara Bio Inc.
11.9.1 Takara Bio Inc. Company Detail
11.9.2 Takara Bio Inc. Business Overview
11.9.3 Takara Bio Inc. mRNA Raw Enzyme Introduction
11.9.4 Takara Bio Inc. Revenue in mRNA Raw Enzyme Business (2019-2024)
11.9.5 Takara Bio Inc. Recent Development
11.10 Novoprotein
11.10.1 Novoprotein Company Detail
11.10.2 Novoprotein Business Overview
11.10.3 Novoprotein mRNA Raw Enzyme Introduction
11.10.4 Novoprotein Revenue in mRNA Raw Enzyme Business (2019-2024)
11.10.5 Novoprotein Recent Development
11.11 Vazyme
11.11.1 Vazyme Company Detail
11.11.2 Vazyme Business Overview
11.11.3 Vazyme mRNA Raw Enzyme Introduction
11.11.4 Vazyme Revenue in mRNA Raw Enzyme Business (2019-2024)
11.11.5 Vazyme Recent Development
11.12 Hongene Biotech Corporatio
11.12.1 Hongene Biotech Corporatio Company Detail
11.12.2 Hongene Biotech Corporatio Business Overview
11.12.3 Hongene Biotech Corporatio mRNA Raw Enzyme Introduction
11.12.4 Hongene Biotech Corporatio Revenue in mRNA Raw Enzyme Business (2019-2024)
11.12.5 Hongene Biotech Corporatio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
